Rx Rundown: Novartis, Boston Scientific, Illumina and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Source: mmm-online.com
Al Robichaud News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Al Robichaud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Al Robichaud Today - Breaking & Trending Today
Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement
Potential growth catalysts include planned 4Q 2023 launch of ZURZUVAE and expected data read-outs for SAGE-718 and SAGE-324 in 2024 Approximately 40% workforce reduction supports focus on agile...
Source: marketscreener.com
Sage Therapeutics to lay off 40% of staff as it gears up for launch of postpartum-depression treatment
Sage Therapeutics Inc. said Thursday it is reorganizing its business operations and workforce as it gears up for the launch of its postpartum-depression...
Source: marketwatch.com
Sage Therapeutics to cut about 188 jobs after depression drug setback
The U.S. Food and Drug Administration (FDA) in early August approved the company and partner Biogen's pill for postpartum depression (PDD), but rejected it as a treatment for clinical depression, which is a much larger market. Sage said the job cuts, which are part of a reorganization plan, will help it launch the drug for women with PDD and also position the company for long-term growth. As part of the reorganization, Sage said its Chief Scientific Officer Al Robichaud will leave the company and will be replaced by Mark Quirk, senior vice president of discovery research.
Source: yahoo.com